China's COVID outbreak intensifies, CDC reveals the danger of the JN.1 variant

Recently, China's National Health Commission declared that the JN.1 variant could evolve into a dominant strain of COVID-19 in China, contributing to the escalation of the pandemic. Mr. Lin, a Changchun City, Jilin Province resident, told Daji Yuan, this wave of the outbreak is especially severe compared to the end of last year. People infected with the virus are showing symptoms of a new coronavirus. However, hospitals and clinics do not administer COVID-19 tests, but only fluids. Mr. Lin revealed that at least half of his daughter's classmates were infected, with some children having chest X-rays showing white lungs immediately after infection. Some children had their lungs washed, and many lung spots developed. However, the government has concealed the outbreak, claiming it is mycoplasma pneumonia. Mr. Lin stated that in the residential areas where he lives, there are 10 buildings, and many people have died, some at home and some in the hospital. There are numerous cases of fever and cough. Two of his sisters have also passed away, and no medication has proven effective. Dr. Gao Hua, a traditional Chinese medicine practitioner, recently posted a video revealing a severe outbreak of mycoplasma pneumonia in Shenyang, Liaoning, affecting many children. The virus has a significant impact on children's health, and if not treated promptly, the resulting complications can be even more terrifying. Li Zhengmao, director of the Planning, Finance, and Regulation Department of China's National Health Commission, stated that due to the continuous invasion of the JN.1 variant and the massive movements of crowds during the Chinese New Year, the variant could develop into the dominant strain of COVID-19 in China. In recent weeks, the JN.1 variant has spread rapidly worldwide, appearing in over 40 countries, including the United States, France, Singapore, and India. The WHO provided a preliminary risk assessment on December 19, listing JN.1 as a variant of concern, stating that compared to other common variants, JN.1 has a significant transmission advantage.